{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T23:27:02Z","timestamp":1794612422360,"version":"4.9.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T00:00:00Z","timestamp":1757116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T00:00:00Z","timestamp":1757116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Histol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10735-025-10588-z","type":"journal-article","created":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T07:18:32Z","timestamp":1757143112000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["CSF2RA promotes gastric cancer progression through activation of the JAK2\/STAT3 signaling pathway"],"prefix":"10.1007","volume":"56","author":[{"given":"Mengjie","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuzhong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anning","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,6]]},"reference":[{"issue":"7812","key":"10588_CR1","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41586-020-2327-4","volume":"582","author":"L Acquaviva","year":"2020","unstructured":"Acquaviva L, Boekhout M, Karasu ME, Brick K, Pratto F, Li T, van Overbeek M, Kauppi L, Camerini-Otero RD, Jasin M et al (2020) Ensuring meiotic DNA break formation in the mouse pseudoautosomal region. Nature 582(7812):426\u2013431","journal-title":"Nature"},{"issue":"42","key":"10588_CR23","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1093\/eurheartj\/ehab447","volume":"42","author":"C Baldini","year":"2021","unstructured":"Baldini C, Moriconi FR, Galimberti S, Libby P, De Caterina R (2021) The JAK-STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms. Eur Heart J 42(42):4389\u20134400","journal-title":"Eur Heart J"},{"issue":"6611","key":"10588_CR10","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1126\/science.abn0478","volume":"377","author":"JM Chan","year":"2022","unstructured":"Chan JM, Zaidi S, Love JR, Zhao JL, Setty M, Wadosky KM, Gopalan A, Choo ZN, Persad S, Choi J et al (2022) Lineage plasticity in prostate cancer depends on JAK\/STAT inflammatory signaling. Science 377(6611):1180\u20131191","journal-title":"Science"},{"issue":"23","key":"10588_CR4","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1182\/blood.2020006846","volume":"138","author":"Y Chang","year":"2021","unstructured":"Chang Y, Min J, Jarusiewicz JA, Actis M, Yu-Chen Bradford S, Mayasundari A, Yang L, Chepyala D, Alcock LJ, Roberts KG et al (2021) Degradation of Janus kinases in CRLF2-rearranged acute lymphoblastic leukemia. Blood 138(23):2313\u20132326","journal-title":"Blood"},{"issue":"10","key":"10588_CR24","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1200\/JCO.19.00895","volume":"38","author":"KT Dao","year":"2020","unstructured":"Dao KT, Gotlib J, Deininger MMN, Oh ST, Cortes JE, Collins RH Jr., Winton EF, Parker DR, Lee H, Reister A et al (2020) Efficacy of ruxolitinib in patients with chronic neutrophilic leukemia and atypical chronic myeloid leukemia. J Clin Oncol 38(10):1006\u20131018","journal-title":"J Clin Oncol"},{"issue":"11","key":"10588_CR12","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/s41423-020-00549-9","volume":"17","author":"R Deng","year":"2020","unstructured":"Deng R, Zuo C, Li Y, Xue B, Xun Z, Guo Y, Wang X, Xu Y, Tian R, Chen S et al (2020) The innate immune effector ISG12a promotes cancer immunity by suppressing the canonical Wnt\/beta-catenin signaling pathway. Cell Mol Immunol 17(11):1163\u20131179","journal-title":"Cell Mol Immunol"},{"issue":"3","key":"10588_CR34","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","volume":"18","author":"J Galon","year":"2019","unstructured":"Galon J, Bruni D (2019) Approaches to treat immune hot, altered and cold tumours with combination immunotherapies. Nat Rev Drug Discov 18(3):197\u2013218","journal-title":"Nat Rev Drug Discov"},{"issue":"7978","key":"10588_CR2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41586-023-06425-6","volume":"621","author":"P Hallast","year":"2023","unstructured":"Hallast P, Ebert P, Loftus M, Yilmaz F, Audano PA, Logsdon GA, Bonder MJ, Zhou W, Hops W, Kim K et al (2023) Assembly of 43 human Y chromosomes reveals extensive complexity and variation. Nature 621(7978):355\u2013364","journal-title":"Nature"},{"issue":"1","key":"10588_CR17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s10020-024-00832-9","volume":"30","author":"J He","year":"2024","unstructured":"He J, Yi J, Ji L, Dai L, Chen Y, Xue W (2024) ECHDC2 inhibits the proliferation of gastric cancer cells by binding with NEDD4 to degrade MCCC2 and reduce aerobic Glycolysis. Mol Med 30(1):69","journal-title":"Mol Med"},{"issue":"13","key":"10588_CR14","doi-asserted-by":"publisher","first-page":"7637","DOI":"10.1111\/jcmm.15399","volume":"24","author":"YL Hu","year":"2020","unstructured":"Hu YL, Feng Y, Chen YY, Liu JZ, Su Y, Li P, Huang H, Mao QS, Xue WJ (2020) SNHG16\/miR-605-3p\/TRAF6\/NF-kappaB feedback loop regulates hepatocellular carcinoma metastasis. J Cell Mol Med 24(13):7637\u20137651","journal-title":"J Cell Mol Med"},{"issue":"1","key":"10588_CR21","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","volume":"6","author":"X Hu","year":"2021","unstructured":"Hu X, Li J, Fu M, Zhao X, Wang W (2021) The JAK\/STAT signaling pathway: from bench to clinic. Signal Transduct Target Ther 6(1):402","journal-title":"Signal Transduct Target Ther"},{"issue":"21","key":"10588_CR33","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1200\/JCO.23.02076","volume":"42","author":"CN Landen","year":"2024","unstructured":"Landen CN, Buckanovich RJ, Sill MW, Mannel RS, Walker JL, DiSilvestro PA, Mathews CA, Mutch DG, Hernandez ML, Martin LP et al (2024) Phase I and randomized phase II study of ruxolitinib with frontline neoadjuvant therapy in advanced ovarian cancer: an NRG oncology group study. J Clin Oncol 42(21):2537\u20132545","journal-title":"J Clin Oncol"},{"issue":"2","key":"10588_CR8","doi-asserted-by":"publisher","first-page":"289","DOI":"10.21147\/j.issn.1000-9604.2025.02.12","volume":"37","author":"H Liu","year":"2025","unstructured":"Liu H, Dilger JP (2025) Different strategies for cancer treatment: targeting cancer cells or their neighbors? Chin J Cancer Res 37(2):289\u2013292","journal-title":"Chin J Cancer Res"},{"key":"10588_CR19","doi-asserted-by":"publisher","first-page":"858756","DOI":"10.3389\/fonc.2022.858756","volume":"12","author":"H Liu","year":"2022","unstructured":"Liu H, Weng J (2022a) A Pan-Cancer bioinformatic analysis of RAD51 regarding the values for diagnosis, prognosis, and therapeutic prediction. Front Oncol 12:858756","journal-title":"Front Oncol"},{"key":"10588_CR20","doi-asserted-by":"publisher","first-page":"146325","DOI":"10.1016\/j.gene.2022.146325","volume":"822","author":"H Liu","year":"2022","unstructured":"Liu H, Weng J (2022b) A comprehensive bioinformatic analysis of cyclin-dependent kinase 2 (CDK2) in glioma. Gene 822:146325","journal-title":"Gene"},{"issue":"5","key":"10588_CR18","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s10142-024-01443-7","volume":"24","author":"H Liu","year":"2024","unstructured":"Liu H, Weng J, Huang CL, Jackson AP (2024) Is the voltage-gated sodium channel beta3 subunit (SCN3B) a biomarker for glioma? Funct Integr Genom 24(5):162","journal-title":"Funct Integr Genomics"},{"issue":"19","key":"10588_CR31","doi-asserted-by":"publisher","first-page":"e70080","DOI":"10.1111\/jcmm.70080","volume":"28","author":"W Mo","year":"2024","unstructured":"Mo W, Deng L, Cheng Y, Ge S, Wang J (2024) IGFBP7 regulates cell proliferation and migration through JAK\/STAT pathway in gastric cancer and is regulated by DNA and RNA methylation. J Cell Mol Med 28(19):e70080","journal-title":"J Cell Mol Med"},{"issue":"2","key":"10588_CR26","doi-asserted-by":"publisher","first-page":"166917","DOI":"10.1016\/j.bbadis.2023.166917","volume":"1870","author":"L Niu","year":"2024","unstructured":"Niu L, Wang Q, Feng F, Yang W, Xie Z, Zheng G, Zhou W, Duan L, Du K, Li Y et al (2024) Small extracellular vesicles-mediated cellular interactions between tumor cells and tumor-associated macrophages: implication for immunotherapy. Biochim Biophys Acta Mol Basis Dis 1870(2):166917","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"3","key":"10588_CR13","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.immuni.2018.03.003","volume":"48","author":"LA O\u2019Reilly","year":"2018","unstructured":"O\u2019Reilly LA, Putoczki TL, Mielke LA, Low JT, Lin A, Preaudet A, Herold MJ, Yaprianto K, Tai L, Kueh A et al (2018) Loss of NF-kappaB1 causes gastric cancer with aberrant inflammation and expression of immune checkpoint regulators in a STAT-1-Dependent manner. Immunity 48(3):570\u2013583 e578","journal-title":"Immunity"},{"issue":"17","key":"10588_CR30","doi-asserted-by":"publisher","first-page":"e37046","DOI":"10.1016\/j.heliyon.2024.e37046","volume":"10","author":"L Ou","year":"2024","unstructured":"Ou L, Liu H, Peng C, Zou Y, Jia J, Li H, Feng Z, Zhang G, Yao M (2024) Helicobacter pylori infection facilitates cell migration and potentially impact clinical outcomes in gastric cancer. Heliyon 10(17):e37046","journal-title":"Heliyon"},{"key":"10588_CR16","doi-asserted-by":"crossref","unstructured":"Peng C, Feng Z, Ou L, Zou Y, Sang S, Liu H, Zhu W, Gan G, Zhang G, Yao M (2023) Syzygium aromaticum enhances innate immunity by triggering macrophage M1 polarization and alleviates Helicobacter pylori-induced inflammation. J Funct Foods 107(105626)","DOI":"10.1016\/j.jff.2023.105626"},{"key":"10588_CR28","doi-asserted-by":"publisher","first-page":"108667","DOI":"10.1016\/j.pharmthera.2024.108667","volume":"259","author":"R Ramapriyan","year":"2024","unstructured":"Ramapriyan R, Vykunta VS, Vandecandelaere G, Richardson LGK, Sun J, Curry WT, Choi BD (2024) Altered cancer metabolism and implications for next-generation CAR T-cell therapies. Pharmacol Ther 259:108667","journal-title":"Pharmacol Ther"},{"issue":"12","key":"10588_CR32","first-page":"1231","volume":"5","author":"Ruxolitinib Benefits Some with Pancreatic Cancer","year":"2015","unstructured":"Ruxolitinib Benefits Some with Pancreatic Cancer (2015) Cancer Discov 5(12):1231","journal-title":"Cancer Discov"},{"issue":"10251","key":"10588_CR7","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F (2020) Gastric cancer. Lancet 396(10251):635\u2013648","journal-title":"Lancet"},{"key":"10588_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","volume":"286\u2013287","author":"D Sonkin","year":"2024","unstructured":"Sonkin D, Thomas A, Teicher BA (2024) Cancer treatments: past, present, and future. Cancer Genet 286\u2013287:18\u201324","journal-title":"Cancer Genet"},{"key":"10588_CR29","doi-asserted-by":"publisher","first-page":"108613","DOI":"10.1016\/j.pharmthera.2024.108613","volume":"256","author":"E Splendiani","year":"2024","unstructured":"Splendiani E, Besharat ZM, Covre A, Maio M, Di Giacomo AM, Ferretti E (2024) Immunotherapy in melanoma: can we predict response to treatment with Circulating biomarkers? Pharmacol Ther 256:108613","journal-title":"Pharmacol Ther"},{"issue":"14","key":"10588_CR3","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1016\/j.cell.2024.04.041","volume":"187","author":"MP Wilson","year":"2024","unstructured":"Wilson MP, Kentache T, Althoff CR, Schulz C, de Bettignies G, Mateu Cabrera G, Cimbalistiene L, Burnyte B, Yoon G, Costain G et al (2024) A pseudoautosomal glycosylation disorder prompts the revision of Dolichol biosynthesis. Cell 187(14):3585\u20133601 e3522","journal-title":"Cell"},{"key":"10588_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biopha.2017.07.071","volume":"94","author":"Z Wu","year":"2017","unstructured":"Wu Z, Ou L, Wang C, Yang L, Wang P, Liu H, Xiong Y, Sun K, Zhang R, Zhu X (2017) Icaritin induces MC3T3-E1 subclone14 cell differentiation through Estrogen receptor-mediated ERK1\/2 and p38 signaling activation. Biomed Pharmacother 94:1\u20139","journal-title":"Biomed Pharmacother"},{"key":"10588_CR6","first-page":"e921233","volume":"26","author":"XJ Xu","year":"2020","unstructured":"Xu XJ, Xin SJ, Mao HY, Zhang HJ, Chen LN, Li L, Bai HL, Huang HH, Shu M (2020) SHOX CNE9\/10 knockout in U2OS osteosarcoma cells and its effects on cell growth and apoptosis. Med Sci Monit 26:e921233","journal-title":"Med Sci Monit"},{"issue":"29","key":"10588_CR5","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1200\/JCO.24.00500","volume":"42","author":"S Yoshimura","year":"2024","unstructured":"Yoshimura S, Li Z, Gocho Y, Yang W, Crews KR, Lee SHR, Roberts KG, Mullighan CG, Relling MV, Yu J et al (2024) Impact of age on pharmacogenomics and treatment outcomes of B-Cell acute lymphoblastic leukemia. J Clin Oncol 42(29):3478\u20133490","journal-title":"J Clin Oncol"},{"issue":"11","key":"10588_CR11","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/nrc3818","volume":"14","author":"H Yu","year":"2014","unstructured":"Yu H, Lee H, Herrmann A, Buettner R, Jove R (2014) Revisiting STAT3 signalling in cancer: new and unexpected biological functions. Nat Rev Cancer 14(11):736\u2013746","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10588_CR27","doi-asserted-by":"publisher","first-page":"166881","DOI":"10.1016\/j.bbadis.2023.166881","volume":"1870","author":"X Yu","year":"2024","unstructured":"Yu X, Zhai X, Wu J, Feng Q, Hu C, Zhu L, Zhou Q (2024) Evolving perspectives regarding the role of the PD-1\/PD-L1 pathway in gastric cancer immunotherapy. Biochim Biophys Acta Mol Basis Dis 1870(1):166881","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"6702","key":"10588_CR25","doi-asserted-by":"publisher","first-page":"eade8520","DOI":"10.1126\/science.ade8520","volume":"384","author":"J Zak","year":"2024","unstructured":"Zak J, Pratumchai I, Marro BS, Marquardt KL, Zavareh RB, Lairson LL, Oldstone MBA, Varner JA, Hegerova L, Cao Q et al (2024) JAK Inhibition enhances checkpoint Blockade immunotherapy in patients with hodgkin lymphoma. Science 384(6702):eade8520","journal-title":"Science"},{"issue":"1","key":"10588_CR22","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","volume":"6","author":"H Zhao","year":"2021","unstructured":"Zhao H, Wu L, Yan G, Chen Y, Zhou M, Wu Y, Li Y (2021) Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduct Target Ther 6(1):263","journal-title":"Signal Transduct Target Ther"}],"container-title":["Journal of Molecular Histology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-025-10588-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-025-10588-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-025-10588-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T05:07:26Z","timestamp":1762837646000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10735-025-10588-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,6]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10588"],"URL":"https:\/\/doi.org\/10.1007\/s10735-025-10588-z","relation":{},"ISSN":["1567-2379","1567-2387"],"issn-type":[{"value":"1567-2379","type":"print"},{"value":"1567-2387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,6]]},"assertion":[{"value":"23 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"297"}}